Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia: a randomized trial

…, T Similowski, A Mercat, JL Diehl, JP Sollet… - Annals of internal …, 2000 - acpjournals.org
Background: Optimal management of patients who are clinically suspected of having
ventilator-associated pneumonia remains open to debate. Objective: To evaluate the effect on …

Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005 …

…, P Montravers, JP Mira, F Gouin, JP Sollet… - Critical care …, 2009 - journals.lww.com
Objective: To describe the evolving epidemiology, management, and risk factors for death of
invasive Candida infections in intensive care units (ICUs). Design: Prospective, …

Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia

H Dupont, H Mentec, JP Sollet, G Bleichner - Intensive care medicine, 2001 - Springer
Objectives: To evaluate the impact of appropriate initial antibiotic therapy (AB) on the
outcome of ventilator-associated pneumonia (VAP). Design: Retrospective study (1992–97). …

FOCUS 1: a randomized, double-blinded, multicentre, phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired …

…, B Misset, B Megarbane, JP Sollet… - Journal of …, 2011 - academic.oup.com
Objectives Ceftaroline, the active form of the prodrug ceftaroline fosamil, is a novel
cephalosporin with bactericidal activity against important pathogens associated with community-…

Severe community-acquired pneumonia as a cause of severe sepsis: data from the PROWESS study

…, R Wunderink, GT Kinasewitz, JP Sollet… - Critical care …, 2005 - journals.lww.com
Sollet has disclosed that he is a consultant/advisor for Chiron and was previously a
consultant/advisor for Eli Lilly & Co. Dr. Maki has disclosed that he has no financial relationships with …

Frequency of infections in cirrhotic patients presenting with acute gastrointestinal haemorrhage

…, R Boulanger, P Squara, JP Sollet… - British Journal of …, 1986 - Wiley Online Library
The frequency of infection at the time of admission with upper gastrointestinal haemorrhage
has been determined in 149 successive cirrhotic patients admitted to an intensive care unit. …

Prevention of intravascular catheter-related infection with newer chlorhexidine-silver sulfadiazine-coated catheters: a randomized controlled trial

C Brun-Buisson, F Doyon, JP Sollet, JF Cochard… - Intensive care …, 2004 - Springer
Background The indication of antiseptic-coated catheters remains debated. Objective To test
the ability of the new generation of chlorhexidine-silver and sulfadiazine-coated catheters, …

Confirmatory platelet-activating factor receptor antagonist trial in patients with severe Gram-negative bacterial sepsis: A phase III, randomized, double-blind, placebo …

…, P Radermacher, MD Schaller, JP Sollet… - Critical care …, 1998 - journals.lww.com
Sollet), Argenteuil, France; Bichat University Hospital (Dr. Wolff), Paris, France; Bourg en
Bresse Hospital (Dr. Holzapfel), Bourg en Bresse, France; Bellevue University Hospital (Dr …

Factors associated with hospital mortality in community-acquired legionellosis in France

…, P Weinbreck, C Brun-Buisson, JP Sollet… - European …, 2012 - Eur Respiratory Soc
The aims of this study were to describe the clinical, biological and radiological features of
community-acquired (CA) Legionnaires’ disease (LD) and identify the predictors of mortality in …

Treatment of ventilator-associated pneumonia with piperacillin-tazobactam/amikacin versus ceftazidime/amikacin: a multicenter, randomized controlled trial

C Brun-Buisson, JP Sollet, H Schweich… - Clinical infectious …, 1998 - academic.oup.com
In a randomized trial conducted in 27 intensive care units, we compared the clinical efficacy
and safety of piperacillin-tazobactam (TAZ; 4 g/0.5 g qid) and of ceftazidime (CAZ; 1 g qid), …